Member Info for rnorth

BOOM TIME!

5? 10? 15 bags?

What's happened or happening here. I still have shares, are they dead and buried yet?

All going to plan. Huge gains to be had here.

Expecting fireworks before the week is out.

You have thohave got so wouldn’t you but look at today.

Because they're locked in with the majority of their holding and want to make money when the fuse is lit in Q1 2018.

Think we were all a little surprised after the volume of buying going in pre-suspension. I wouldn't worry too much though, nothing has really changed other than the SP has dropped a little bit. The company is just doing it's thing and commercialising it's IP...that takes time. Should see some news early in the new year I expect.

I feel someone is loading up big time here.

Perhaps, headinthesand, you should pull your head out understand the ‘ramp fest’ are actually all loaded up and just sat quietly waiting for the first commercial deal to be detailed.

Exactly. I've just switched off now and check in every so often. Too much rubbish getting spouted by trolls before.

Could it be that reeves and Hughes are offloading loads of their shares? Can’t understand any obvious reason for the drop to be honest.

Content very positive. I’d imagine the testing will be pretty quick as it is simply a case of checking the absorption rate is faster than the standard drug form and ticking a few boxes to ensure side effects are no worse. In my head this should only take a month max then get the licensing out - which will already be well under discussion subject to positive trial. Instant cash injection to underpin the SP but I expect it to bag on that first deal, at least. Possibly two bag. When people realise the value of the patents already filed they will understand why Abman suggested a 20p short term target. Basically five times from this Mcap would be the mooted value of the first three patents if they were sold outright - more if licenced, as is the plan with 001.

http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf

The thing is, everyone needs to do their own research. I've no doubt they're both invested here, with some clout too but have probably got in at the price they want and are off just off living their life for now. Will be back at some point as I know they're both very positive about this company. They are also pretty honest about the fact the have a holding plus some they trade. Personally I like the balanced views, as long as there is foundation for it. I do tend to get carried away with the rampy stuff as it often has some foundation. For me this is one of a very few companies that has a huge amount going for it. We're looking at licencing deals, potentially, before Easter 2018 plus 002 progressing swiftly too. Just because it has not been broadcast yet or any deals officially tied up does not mean we are not on the radars of some major players. There is a very big picture at large here and if you dig deep enough you'll find some very important, albeit seemingly tenuous links. I took the opportunity to top up. I didn't expect a drop due to the demand prior to suspension but suspension took a long time. News during that period was very limited so I am banking on them being a little more forthcoming - which isn't always the way the science types operate if you look at the US markets, typically. That said, they have produced a pitch and a marketing video to ensure people understand what they're investing in to which is a good idea IMHO. We're main market and biotech is big business with limited opportunities. Historically where biotech has entered the markets it's either been led by scientists who do not understand investors, or by bankers who do not fully understand the science. This is why people like Naz say don't get your fingers burnt, because of the latter example. Pascal is in this arena in my opinion, and Reeves. But they sure know how to get finance traction and no doubt have made a few quid off this already. Fair play to them, it has been a well worked deal. Now we have world leading scientists taking patent driven deals to the commercial markets in various forms with support from the money men who have a vested interest. It's a formula that should work on licensing and sale and should make for a very interesting buy out in the future. If no buy out it will be a business that's worth plenty if they get the deals to market - for which the outlay is minimal as the co-crystal approach falls within clear parameters for testing/trials so speed to market could be very quick indeed, which means lots of money in short period of time. Just IMVHO. DYOR etc etc.

Naz - I've never seen you on this board before. Many here were in before suspension and are well aware of the risks, as well as the potential. We wouldn't have come on board knowing our money would be locked in to a suspension if we were not confident in the people involved and the potential to unlock value in the patents granted.

...like a bed and isa has dropped the price down. Movement on this will rocket once investors realise what potential there is and it's Main Market. Sit tight.

Expecting some big ones today then a bit of attention into the rest of the week.

Correct me if I'm wrong but we're on the main market, not AIM. Sort of nullifies some of the drivel on here.

To be fair those same names picked up CTAG under 2p and watched it rise to ten times that with placing at a premium. No reason not to believe what the company was saying when other II's were investing at premiums. We're picking this up at the bottom and it clearly has some great growth potential. Why not get excited about a share and bring all the positive stuff to the forum. Also open to any negative stuff but only if it's based on anything solid. It just comes down to research and your approach to risk. I had a good chunk in here and chose to double up this morning. I'm confident in my investment.